Therapeutic Candidate Equipment
-
Manufactured by Regeneron Pharmaceuticals Inc.based in USA
elociT™ is our unique mouse technology for producing fully human therapeutic T-cell receptors (TCR) against tumor and viral antigens. Regeneron uses this technology as part of its efforts to discover and develop novel immuno-oncology therapeutic candidates, including combination approaches and to assist our collaborators in producing ...
-
based in USA
and biologics. Using cell-based expression systems to produce protein variants is also a cumbersome way to enable selection of the best therapeutic ...
-
Manufactured by Ocugen, Inc.based in USA
an important role in lipid metabolism and demonstrates an anti-inflammatory role, which we believe could be a potential therapeutic candidate for dry ...
-
Manufactured by Catalent, Incbased in USA
, with 160+ clinical trials utilizing therapeutic candidates developed using GPEx technology and 16 commercially-approved products. ...
-
Manufactured by Vascugen Inc.based in USA
Development of complex iPSC-based therapeutics benefits from an engineering mindset. Each layer of the development and manufacturing process is considered part of the ‘Full Stack’ that leads to finished product. An integrated stepwise approach improves the probability of arriving at the right therapeutic candidate and ...
-
Manufactured by Lung Therapeutics, Inc.based in USA
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by progressive tissue scarring that prevents proper lung function. LTI-03 operates through a novel mechanism of action (MOA) that is unlike any MOA seen in the therapeutic candidates of today. By targeting healthy epithelial cells, LTI-03 promotes the protection of ...
-
Manufactured by HTG Molecular Diagnostics, Inc.based in USA
The initial focus of HTG Therapeutics will be to identify development candidates targeting RNA or RNA modifying proteins, which could be relevant in areas such as oncology, immunology, diabetes, and rare disease. HTG’s EdgeSeq and Epi-EdgeSeq technology is a foundational element in our drug discovery programs. It enables a more ...
-
Manufactured by TC BioPharmbased in UNITED KINGDOM
system's innate response, their natural properties make them promising therapeutic candidates. This review demonstrates the historical work on GDT cell therapies, and the promise offered by combinations or modifying them with ...
-
based in POLAND
forms of this disease. In the PB001 project, Pure Biologics aims to develop a recombinant bispecific antibody as a therapeutic candidate for immunotherapy in colorectal ...
-
based in USA
AlOptimus™ brings to bear AINovo's proprietary machine learning algorithms on our highly curated datasets to enhance the therapeutic profiles of drug candidates. The AlOptimus platform optimizes validated candidates to derisk development and inform clinical ...
-
Manufactured by Siolta Therapeuticsbased in USA
to rationally design and optimize multi-strain live biotherapeutics for the prevention and treatment of diseases of high unmet medical need. Top therapeutic candidates are manufactured in-house under cGMP conditions ensuring pharmaceutical-grade purity, potency, and consistency. Siolta’s streamlined internal capabilities and expertise rapidly drives ...
-
based in BELGIUM
The MYASTERIX project (2013 – 2018) advanced a Therapeutic Vaccine candidate (designated orphan drug) indicated for myasthenia gravis (MG) to clinical proof of concept ...
-
Manufactured by VECT-HORUSbased in FRANCE
conjugated to a payload, enable its delivery to target cells in the body. In other words, Vect-Horus’ core expertise relies on modifying pharmacokinetic (PK) and distribution profile of therapeutic or imaging candidates. ...
-
based in ITALY
What makes us unique is the power of our computational platform, which enables us to reconstruct the series of conformational rearrangements underlying the process of protein folding at an atomistic level of ...
-
by Redbiotec AGbased in SWITZERLAND
Redbiotec specializes in developing high-quality vaccines to fight difficult diseases. After successfully spinning out the CMV vaccine program that was acquired by Pfizer, Redbiotec is currently developing HSV-2 therapeutic vaccine ...
-
Manufactured by Codexis, Inc.based in USA
Achieve exceptional IVT results with Codex® HiCap RNA Polymerase, a co-transcriptional capping RNA polymerase that has been uniquely engineered to produce synthetic mRNA at high yield and low ...
-
Manufactured by Rocket Pharmaceuticals, Inc.based in USA
and isolation of a patient’s hematopoietic stem cells (HSCs), insertion of the corrected gene into the HSCs via a lentiviral vector outside the body, and the infusion of modified HSCs back into the patient. The goal is to enable sufficient quantities of a healthy, disease-modifying therapeutic protein to be manufactured by the patients’ ...
-
Manufactured by Rocket Pharmaceuticals, Inc.based in USA
and isolation of a patient’s hematopoietic stem cells (HSCs), insertion of the corrected gene into the HSCs via a lentiviral vector outside the body, and the infusion of modified HSCs back into the patient. The goal is to enable sufficient quantities of a healthy, disease-modifying therapeutic protein to be manufactured by the patients’ ...
-
Manufactured by Mimetas B.V.based in NETHERLANDS
Profiling and screening of your compounds with a high throughput barrier integrity assay on our established Caco-2 intestinal model. OrganoServices are available for multiple assays to allow compound profiling and/or screening in human-relevant, complex 3D tissue models. When developing new drugs, it is critical to understand the permeability, absorption, and transport mechanisms in relevant ...
-
Manufactured by Ncardia Services B.V.based in NETHERLANDS
and can scale it up for high-throughput screening, to accurately evaluate efficacy and safety of drug candidates early in drug ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you